top-selling glp-1 medications in the u.s. 2025 How Supply and Demand for Weight Loss Drugs is Playing Out 2026 GLP-1 Market Size, Share |

This is the Sunset difference

Clinical trials have demonstrated substantial weight reduction, with participants losing approximately 15-20% of their body weight over 72 weeks when combined with lifestyle modifications, though results vary by dose and patient population

Under normal metabolic conditions, endogenous glutathione production keeps pace with oxidative load

Furthermore, Fer-1 mitigates oxidative stress by downregulating prostaglandin endoperoxide synthase 2 while upregulating GPX4 and Nrf2, thereby decreasing lipid peroxidation (115)

GLP-1 medications are generally regarded as safe for most patients when prescribed by a qualified healthcare provider